CHRISTOPHER SULLIVAN plan to sell securities of AVALO THERAPEUTICS, INC. under Form 144
2026-05-06SEC Filing 144 (0001950047-26-004142)
CHRISTOPHER SULLIVAN filed Form 144 to notify SEC of plan to sell 47000 units of AVALO THERAPEUTICS, INC. securities around 2026-05-06, with aggregate market value of $764,220.00. The total outstanding units is 22788452.0. The amount planned to be sold represents 0.21% of total outstanding units; Recent transactions in past 3 months include: On 04/30/2026, sold 8457 units for $111853.13; On 04/29/2026, sold 8458 units for $110736.37; On 04/02/2026, sold 7980 units for $136822.69; On 04/01/2026, sold 7979 units for $133770.33;